insitro.comHealthcare / BioTech & PharmaFounded: 2018Funding to Date: $628.63MM
Insitro is a drug discovery and development business using machine learning methods to create predictive models for treatments. Insitro's use of technology and quantitative biology aims to model disease and develop new therapies. Insitro was founded in 2018 by Daphne Koller Ph.D. and is headquartered in San Francisco, CA.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
03/15/2021 | Series C | $400MM | $xx.xx | $2.57B | CPP Investments, Andreessen Horowitz, T. Rowe Price, Casdin Capital, BlackRock, ARCH Venture Partners, Foresite Capital, GV, Third Rock Ventures, Two Sigma Ventures, HOF Capital, Alexandria Venture Investments, Temasek, Softbank | |
Price per Share
$xx.xx
Shares Outstanding
21,868,541
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
CPP Investments, Andreessen Horowitz, T. Rowe Price, Casdin Capital, BlackRock, ARCH Venture Partners, Foresite Capital, GV, Third Rock Ventures, Two Sigma Ventures, HOF Capital, Alexandria Venture Investments, Temasek, Softbank
|
||||||
05/26/2020 | Series B | $149.22MM | $xx.xx | $725.03MM | Andreessen Horowitz, CPP Investments, T. Rowe Price, BlackRock, Casdin Capital, HOF Capital, WuXi AppTec, ARCH Venture Partners, Foresite Capital, GV, Third Rock Ventures, Two Sigma Ventures, Alexandria Venture Investments | |
Price per Share
$xx.xx
Shares Outstanding
23,949,729
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Andreessen Horowitz, CPP Investments, T. Rowe Price, BlackRock, Casdin Capital, HOF Capital, WuXi AppTec, ARCH Venture Partners, Foresite Capital, GV, Third Rock Ventures, Two Sigma Ventures, Alexandria Venture Investments
|
||||||
05/01/2018 | Series A-2 | $49.41MM | $xx.xx | $309.11MM | a16z, Arch Venture, Foresite Capital, GV, Third Rock Ventures, Alexandria Venture, Bezos Expeditions, Mubadala Investment Company, Two Sigma Ventures, Verily | |
Price per Share
$xx.xx
Shares Outstanding
18,359,806
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
a16z, Arch Venture, Foresite Capital, GV, Third Rock Ventures, Alexandria Venture, Bezos Expeditions, Mubadala Investment Company, Two Sigma Ventures, Verily
|
||||||
05/01/2018 | Series A-1 | $30MM | $xx.xx | $309.11MM | a16z, Arch Venture, Foresite Capital, GV, Third Rock Ventures, Alexandria Venture, Bezos Expeditions, Mubadala Investment Company, Two Sigma Ventures, Verily | |
Price per Share
$xx.xx
Shares Outstanding
33,327,366
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
a16z, Arch Venture, Foresite Capital, GV, Third Rock Ventures, Alexandria Venture, Bezos Expeditions, Mubadala Investment Company, Two Sigma Ventures, Verily
|